RESUMO
How far do marine larvae disperse in the ocean? Decades of population genetic studies have revealed generally low levels of genetic structure at large spatial scales (hundreds of kilometres). Yet this result, typically based on discrete sampling designs, does not necessarily imply extensive dispersal. Here, we adopt a continuous sampling strategy along 950 km of coast in the northwestern Mediterranean Sea to address this question in four species. In line with expectations, we observe weak genetic structure at a large spatial scale. Nevertheless, our continuous sampling strategy uncovers a pattern of isolation by distance at small spatial scales (few tens of kilometres) in two species. Individual-based simulations indicate that this signal is an expected signature of restricted dispersal. At the other extreme of the connectivity spectrum, two pairs of individuals that are closely related genetically were found more than 290 km apart, indicating long-distance dispersal. Such a combination of restricted dispersal with rare long-distance dispersal events is supported by a high-resolution biophysical model of larval dispersal in the study area, and we posit that it may be common in marine species. Our results bridge population genetic studies with direct dispersal studies and have implications for the design of marine reserve networks.
Assuntos
Fluxo Gênico , Genética Populacional , Animais , Humanos , Larva/genética , Mar MediterrâneoRESUMO
Venous thromboembolism (VTE) is one of the leading causes of maternal deaths worldwide. Due to the increasing number of pregnant women with risk factors, the incidence of VTE has risen over the past decades. Mortality and morbidity of VTE are potentially preventable, since more than two-thirds of these women have identifiable risk factors and may benefit from appropriate thromboprophylaxis. The cornerstones for prevention of VTE are the individual and careful assessment of preexisting and new-onset/transient risk factors during pregnancy as well as before and after delivery and a risk-stratified pharmacological thromboprophylaxis. Current recommendations for thromboprophylaxis must rely on consensus statements and expert opinions. The recently published German AWMF-Guideline 003/001 and the Green-top Guideline No. 37a from the Royal College of Obstetricians and Gynaecologists (RCOG) are discussed. The RCOG Guideline recommends antenatal thromboprophylaxis in women with previous VTE, high-risk thrombophilia or in the presence of ≥ 4 risk factors from the beginning of pregnancy, in women with 3 current risk factors from 28 weeks of gestation. After delivery women with intermediate risk should receive prophylactic LMWH for at least 10 days and women with high risk for 6 weeks postnatally. All women who have had an elective caesarean section and who have>1 additional risk factor should be given prophylactic NMH as well as all women who have had a caesarean section in labour or an emergency caesarean section. At the onset of labour, in case of any vaginal bleeding, prior to scheduled labour induction or at least 12 h before an elective caesarean section, antenatal LMWH prophylaxis should be discontinued. LMWH prophylaxis can be continued 4-6 h after vaginal delivery and 6-12 h after caesarean delivery when women do not have an increased risk of haemorrhage. Current guidelines recommend weight-based LMWH.
Assuntos
Anticoagulantes/administração & dosagem , Fibrinolíticos/administração & dosagem , Obstetrícia/normas , Guias de Prática Clínica como Assunto , Complicações Cardiovasculares na Gravidez/prevenção & controle , Tromboembolia Venosa/prevenção & controle , Medicina Baseada em Evidências , Feminino , Alemanha , Heparina de Baixo Peso Molecular/administração & dosagem , Humanos , Gravidez , Complicações Cardiovasculares na Gravidez/diagnóstico , Complicações Cardiovasculares na Gravidez/tratamento farmacológico , Resultado do Tratamento , Reino Unido , Tromboembolia Venosa/diagnóstico , Tromboembolia Venosa/tratamento farmacológicoRESUMO
BACKGROUND: The prevention and treatment of preterm birth remains an unsolved problem in modern obstetrics. Progesterone has a variety of actions on the myometrium and the cervix, among others inhibition of myometrial contractility and a cervix strengthening effect by inhibiting the production of proinflammatory cytokines and prostaglandins as well as by reducing the synthesis of proteins, which play a crucial role in initiating labour. Consequently, progesterone may be a promising candidate for the prevention of preterm birth. MATERIAL AND METHODS: We searched PubMed from 1956 to August 2014 using a combination of key words and text words related to preterm birth and progesterone. ('progesterone', progestins, 17-OHPC). The aim of the literature search was to determine evidence-based indications for the use of progesterone in the prevention of preterm birth. RESULTS: (i) Patients with a singleton pregnancy and history of preterm birth should receive vaginal progesterone daily (200 mg capsule or 90 mg containing gel) from 16+0 to 36+0 weeks of gestation (alternatively 250 mg intramuscular 17-OHPC weekly): level of evidence 1a, grade of recommendation ++ . Prophylactic progesterone reduces the incidence of preterm birth <34 and <37 weeks of gestation and perinatal mortality significantly. (ii) Patients with singleton pregnancies and a sonographically short cervix (≤25 mm) before 24 weeks of gestation should receive vaginal progesterone daily (200 mg capsule or 90 mg containing gel) until 36+6 weeks of gestation: level of evidence 1a, grade of recommendation ++ . Prophylactic progesterone leads to a significant reduction in the incidence of preterm birth <28, <33, and <35 weeks of gestation and is associated with a significant reduction of neonatal morbidity. (III) There is a lack of evidence to recommend vaginal progesterone or intramuscular 17-OHPC for primary tocolysis or for "adjunctive" tocolysis (in combination with conventional tocolytic agents). (IV) There is a growing body of evidence that vaginal progesterone (400 mg/day) after successful tocolysis ("maintenance therapy") is a promising option for prolongation of pregnancy: level of evidence 1b, grade of recommendation +. (V) Data from the literature are insufficient to recommend progesterone in patients with preterm rupture of membranes or in the perioperative management of patients requiring transvaginal cervical cerclage. (VI) The vaginal administration of progesterone is well-tolerated by the patients and has only minor maternal side effects, whereas intramuscular injections of 17-OHPC are associated with a significant higher rate of side effects (e. g. local pain, nausea, diarrhoea). It is mandatory to inform patients on the off-label use of progesterone in pregnancy. DISCUSSION: Prophylactic progesterone administration is an evidence-based method for the prevention of preterm birth in women with a previous preterm birth and in pregnant women with a sonographically short cervix (≤25 mm) before 24 weeks of gestation. Vaginal progesterone is favoured over intramuscularly applied 17-OHPC, especially because of the lower rate of maternal side effects. Whether progesterone is an effective approach for the treatment of preterm birth as a tocolytic agent (primary, adjunctive) or for maintenance therapy after arrest of preterm labour has to be shown in further well-designed randomised and controlled trials with adequate statistical power.
Assuntos
Morte Perinatal/prevenção & controle , Nascimento Prematuro/diagnóstico , Nascimento Prematuro/mortalidade , Progesterona/administração & dosagem , Medicina Baseada em Evidências , Feminino , Humanos , Incidência , Gravidez , Progestinas/administração & dosagem , Fatores de Risco , Taxa de Sobrevida , Resultado do TratamentoRESUMO
Postpartum hemorrhage (PPH) is one of the main causes of maternal deaths even in industrialized countries. It represents an emergency situation which necessitates a rapid decision and in particular an exact diagnosis and root cause analysis in order to initiate the correct therapeutic measures in an interdisciplinary cooperation. In addition to established guidelines, the benefits of standardized therapy algorithms have been demonstrated. A therapy algorithm for the obstetric emergency of postpartum hemorrhage in the German language is not yet available. The establishment of an international (Germany, Austria and Switzerland D-A-CH) "treatment algorithm for postpartum hemorrhage" was an interdisciplinary project based on the guidelines of the corresponding specialist societies (anesthesia and intensive care medicine and obstetrics) in the three countries as well as comparable international algorithms for therapy of PPH.The obstetrics and anesthesiology personnel must possess sufficient expertise for emergency situations despite lower case numbers. The rarity of occurrence for individual patients and the life-threatening situation necessitate a structured approach according to predetermined treatment algorithms. This can then be carried out according to the established algorithm. Furthermore, this algorithm presents the opportunity to train for emergency situations in an interdisciplinary team.
Assuntos
Algoritmos , Hemorragia Pós-Parto/terapia , Adulto , Anestesiologia/normas , Áustria , Consenso , Serviços Médicos de Emergência , Feminino , Alemanha , Guias como Assunto , Humanos , Recém-Nascido , Cooperação Internacional , Obstetrícia/normas , Equipe de Assistência ao Paciente , Hemorragia Pós-Parto/diagnóstico , Hemorragia Pós-Parto/mortalidade , Gravidez , Fatores de Risco , SuíçaRESUMO
The average age of childbearing has risen markedly in Germany and other high-income countries during the past 2 decades. Women aged 35 years or older have an increase in pregnancy complications and in preexisting medical conditions including obesity, diabetes and hypertension as well as a significant increase in the gestational age-related rate of stillbirth compared to younger mothers. Additional individual risk factors for stillbirth are primiparity, body mass index>30 and smoking. After exclusion of risk factors the absolute risk of stillbirth in women aged≥40 years old is 2-fold higher (1 in 503 maternities) at 39/40 weeks of gestation compared to women aged<35 years (1 in 1 020 maternities) at the same gestational age. Women aged 40 years or older have a similar stillbirth risk at 39 weeks of gestation to 25-29-year-olds at 41 weeks gestation. The underlying mechanism for the excess risk of stillbirth in women of advanced maternal age after exclusion of congenital anomalies is unknown. Independent of maternal age the cumulative probability of perinatal death increases from 1.8/1 000 deliveries at 38 weeks of gestation to 9.3/1 000 deliveries at 42 weeks of gestation. Whether on the basis of these data induction of labour at 39 weeks of gestation should be recommended in women of advanced maternal age has recently been discussed in a Scientific Impact Paper of the Royal College of Obstetricians and Gynaecologists. In this context it should be taken into account that the rate of Caesarean sections in women aged 40 years or over is 40%, and, in particular, older nulliparous may request elective Caesaran section rather than elective induction of labour. Recent metaanalyses have shown that elective induction of labour before or after term is not associated with an increase of the Caesarean section rate compared to expectant management. Up to now no randomised controlled trials exist and consequently no -recommendations from current guidelines regarding induction of labour in women of advanced maternal age can be given. In any case, a careful consultation and an individual risk-benefit analysis regarding the obstetric management is mandatory, and the final decision should be made in agreement between the pregnant women and the obstetrician. Currently a randomised controlled trial in the U.K. comparing induction of labour at 39 weeks of gestation with expectant management in nulliparous women aged over 35 years is recruiting, with the aim to determine intrapartum complications and perinatal morbidity and mortality in both managements.
Assuntos
Cesárea/métodos , Cesárea/estatística & dados numéricos , Trabalho de Parto Induzido/mortalidade , Trabalho de Parto Induzido/estatística & dados numéricos , Idade Materna , Natimorto/epidemiologia , Adulto , Distribuição por Idade , Feminino , Alemanha/epidemiologia , Humanos , Incidência , Pessoa de Meia-Idade , Fatores de Risco , Taxa de Sobrevida , Adulto JovemRESUMO
Post-partum haemorrhage (PPH) is the leading cause of maternal mortality worldwide. Since more than 50 years AMTSL has been proposed for the prevention of PPH and is still recommended in current guidelines. The 3 key components of AMTSL are the prophylactic administration of oxytocin, clamping and cutting of the umbilical cord immediately after delivery of the baby and controlled cord traction. AMTSL has proven to reduce the rate of severe PPH by 70%. Despite of the long tradition of AMTSL it is still unclear, which of the 3 components significantly contributes to the reduction in PPH. Cochrane analyses and a recent metaanalysis gave strong evidence, that prophylactic oxytocin administration reduces the risk of PPH significantly, however, the optimal dose and mode of application is still a matter of debate.Until a little while ago no randomized controlled studies exist regarding the significance of controlled cord traction and the time of cord clamping in AMTSL. A randomized WHO trial 2012 and the 2013 published TRACOR (Traction of the CORd)-trial from France could clearly demonstrate that controlled cord traction is not associated with a significant reduction in postpartum blood loss and in the risk of severe PPH. A Cochrane analysis 2008 and a recent randomized trial from Sweden came to the conclusion, that there are no significant -differences between early (< 15 s) and delayed (> 1-3 min) cord clamping in the reduction of PPH and severe PPH. Uterine massage after delivery of the placenta, placental cord drainage and umbilical vein injection of uterotonics after delivery of the baby as part of AMTSL are not evidence-based methods. It has taken 50 years since AMTSL was first described for it to become clear that prophylactic oxytocin is the most important and the only evidence-based component of AMTSL. Future guidelines and textbooks should consider these new -findings.
Assuntos
Complicações do Trabalho de Parto/epidemiologia , Complicações do Trabalho de Parto/prevenção & controle , Obstetrícia/normas , Hemorragia Pós-Parto/epidemiologia , Hemorragia Pós-Parto/prevenção & controle , Guias de Prática Clínica como Assunto , Medicina Baseada em Evidências , Feminino , Alemanha/epidemiologia , Humanos , Trabalho de Parto/fisiologia , Ocitócicos/uso terapêutico , Ocitocina/administração & dosagem , Gravidez , Prevalência , Fatores de Risco , Resultado do TratamentoRESUMO
Acute maternal Parvovirus B19 infection affects about 1% of all pregnancies worldwide. Diaplacental transmission of Parvovirus B19 during the second trimester can cause complications like foetal hydrops, premature delivery or foetal loss in about 20-30% of these pregnancies, whereas the majority of maternal infections remain clinically silent. In individual cases, foetoplacental hydrops (of various origins) can trigger a rare form of Preeclampsia in the pregnant woman. The developing maternal oedema in this situation apparently "mirrors" the hydropic state of the foetus. The symptom triad of foetal hydrops, foetoplacental oedema and maternal anasarca defines Ballantyne syndrome. We report a case of Parvovirus-induced Ballantyne syndrome including a 10-year follow-up of mother and child. While the mother recovered rapidly after (preterm) delivery, the infection complicated the first months of life of the neonate. Congenital transfusion-dependent red cell aplasia and cholestatic hepathopathy took a chronic course but resolved under IVIG treatment. Follow-up now finds both the former neonate and the mother entirely recovered. Current knowledge on Ballantyne syndrome as well as perigestational Parvovirus infections including congenital anaemia is briefly reported and pathophysiological hypotheses are discussed.
Assuntos
Anemia/congênito , Anemia/diagnóstico , Eritema Infeccioso/diagnóstico , Hidropisia Fetal/diagnóstico , Pré-Eclâmpsia/diagnóstico , Adulto , Anemia/terapia , Anemia/virologia , Diagnóstico Diferencial , Eritema Infeccioso/terapia , Feminino , Humanos , Hidropisia Fetal/terapia , Hidropisia Fetal/virologia , Pré-Eclâmpsia/terapia , Gravidez , Síndrome , Resultado do TratamentoRESUMO
Pregnancy-related complications not only represent a risk for maternal and fetal morbidity and mortality, but are also a risk for several diseases later in life. Many epidemiological studies have shown clear associations between an adverse intrauterine environment and an increased risk of diabetes, hypertension, cardiovascular disease, depression, obesity, and other chronic diseases in the adult. Some of these syndromes could be prevented by avoiding adverse stimuli or insults including psychological stress during pregnancy, intake of drugs, insufficient diet and substandard working conditions. Hence, all of these stimuli have the potential to alter health later in life. The placenta plays a key role in regulating the nutrient supply to the fetus and producing hormones that control the fetal as well as the maternal metabolism. Thus, any factor or stimulus that alters the function of the hormone producing placental trophoblast will provoke critical alterations of placental function and hence could induce programming of the fetus. The factors that change placental development may interfere with nutrient and oxygen supply to the fetus. This may be achieved by a direct disturbance of the placental barrier or more indirectly by, e. g., disturbing trophoblast invasion. For both path-ways, the respective pathologies are known: while preeclampsia is caused by alterations of the villous trophoblast, intra-uterine growth restriction is caused by insufficient invasion of the extravillous trophoblast. In both cases the effect can be undernutrition and/or fetal hypoxia, both of which adversely affect organ development, especially of brain and heart. However, the mechanisms responsible for disturbances of trophoblast differentiation and function remain elusive.
Assuntos
Desenvolvimento Fetal , Doenças Fetais/fisiopatologia , Troca Materno-Fetal , Modelos Biológicos , Placenta/fisiopatologia , Adulto , Feminino , Humanos , Masculino , GravidezRESUMO
INTRODUCTION: Postpartum haemorrhage (PPH) remains to be the most common cause of maternal mortality and is responsible for 25 % of the maternal deaths worldwide. Although the absolute risk of maternal death is much lower, a recent increase of PPH and related maternal adverse outcomes has been noted in high-income countries as well. Generally, PPH requires early recognition of its cause, immediate control of the bleeding source by medical, mechanical, invasive-non-surgical and surgical procedures, rapid stabilization of the mother's condition, and a multidisciplinary approach. Second-line treatment of PPH remains challenging, since there is a lack of univocal recommendations from current guidelines and sufficient data from randomized controlled trials. MATERIALS: For this review, electronic searches were performed in PubMed, Embase, and the Cochrane Central Register of Controlled Trials using the keywords "postpartum haemorrhage" in combination with 'uterine tamponade' and, especially with 'arterial embolisation', 'uterine compression sutures', and 'post(peri)partum hysterectomy' (from January 2000 to November 2011). Reference lists of identified articles were searched and article references to the keywords selected. RESULTS: Treatment options such as uterine compression sutures, embolisation, arterial ligation and hysterectomy were evaluated with regard to their prerequisites, benefits, drawbacks and respective success rate. In addition, a treatment algorithm for the second-line treatment of PPH is presented.
Assuntos
Hemorragia Pós-Parto/terapia , Feminino , Humanos , Histerectomia , Ligadura , Guias de Prática Clínica como Assunto , Gravidez , Técnicas de Sutura , Embolização da Artéria Uterina , Tamponamento com Balão UterinoRESUMO
BACKGROUND: The time window for measuring blood gases in the umbilical cord after birth is often discussed controversial with regard to birth damage claims. METHODS: 53 umbilical cords from spontaneous deliveries at term were double clamped at room temperature directly after birth and paired arterial and venous samples were taken at 0,5, 10, 20, 40, 60 and 120 min. Arterial and venous blood gases [pH, pO2, pCO2, base-excess (BE)] were measured. Statistical analyses were performed with the t test and Wilcoxon test. RESULTS: We measured data from (arterial/venous) pH 7.27±0.06 or, respectively, 7.34±0.06; BE 3.36±3.42 or, respectively, 3.64±2.58, pCO2 48.6±7.6 or, respectively, 38.6±6.4 mmHg (p<0.001). The arterial and venous pH dropped significantly by 0.02 (p<0.001) at 5 min. The arterial cord base excess dropped significantly to 2 mmol/L (p<0.001) at 5 min. The venous cord base excess dropped slowly at 40 min. Arterial and venous pO2 readings did not drop significantly, but the mean value showed variations. Arterial and venous pCO2 values increased significantly within 40 or, respectively, 60 min. Actual literature reports differ dramatically in the increase or decrease of blood gas parameters. DISCUSSION: Storage of the umbilical cord with room temperature results in changes in blood gas results within a short time of period. To avoid controversial discussion in civil court proceedings the blood gas probes from the umbilical cord should be analysed immediately after birth or stored in heparinised cooled syringes.
Assuntos
Equilíbrio Ácido-Base/fisiologia , Asfixia Neonatal/sangue , Asfixia Neonatal/diagnóstico , Gasometria , Coleta de Amostras Sanguíneas , Prova Pericial/legislação & jurisprudência , Sangue Fetal/fisiologia , Manejo de Espécimes , Feminino , Humanos , Recém-Nascido , Valor Preditivo dos Testes , Gravidez , Estudos Prospectivos , Fatores de TempoRESUMO
BACKGROUND: Oxidised low density lipoproteins (oxLDL) are key players in the development of atherosclerotic cardiovascular diseases. Since there are similarities between the pathogenesis of preeclampsia and atherosclerosis we hypothesised an increased accumulation of oxLDL at the materno-foetal and foeto-foetal interface within the placental tissue of preeclamptic women compared to women with normotensive pregnancies (controls). Moreover, we analysed maternal and foetal serum lipid parameters. PATIENTS AND METHODS: oxLDL was determined by immunohistochemistry in placental paraffin sections of 14 women suffering from preeclampsia (30th-39th week of gestation) and compared to 28 preterm and term deliveries (25th-40th week of gestation). 10 high power fields were chosen randomly by the newCAST software and oxLDL expression was analysed via standardised methods by 2 independent and blinded investigators. Maternal and foetal triglycerides, total cholesterol, LDL cholesterol and HDL cholesterol were measured. Statistical examination was carried out by the Mann-Whitney test. RESULTS: oxLDL was found in villous trophoblast and placental endothelium. No significant differences were observed in expression intensity between preeclampsia and controls. Maternal and foetal triglyceride levels were significantly increased in preeclampsia compared to controls (pre-eclampsia mothers: 293 [SD 87.4] mg/dL, controls: 214 [SD 89.4] mg/dL, p=0.0097; preeclampsia foetuses: 26 [SD 16.6] mg/dL, controls: 18 [SD 10.4] mg/dL, p=0.0463). No significant differences in other lipid concentrations were found. CONCLUSIONS: We could not confirm our initial hypothesis of an increased oxLDL accumulation in placental tissue of preeclampsia. However, preeclampsia is a condition of dyslipidaemia affecting both maternal and foetal serum with implications for development and programming of cardiovascular diseases in later life.
Assuntos
Sangue Fetal/metabolismo , Lipídeos/sangue , Lipoproteínas LDL/sangue , Troca Materno-Fetal , Placenta/metabolismo , Pré-Eclâmpsia/sangue , Adulto , Biomarcadores , Feminino , Humanos , Gravidez , Reprodutibilidade dos Testes , Sensibilidade e EspecificidadeRESUMO
Venous thromboembolism (VTE) is one of the leading causes of maternal deaths worldwide. Mortality and morbidity of VTE are potentially preventable, since two-thirds of these women have identifiable risk factors and may benefit from appropriate thromboprophylaxis. Individual and careful assessment of the personal and family history as well as the assessment of pre-existing and new-onset/transient risk factors during pregnancy and after delivery are mandatory for an effective prevention of VTE. Current guidelines (American College of Chest Physicians 2008, AWMF-Guideline 003/001 2009 and the Royal College Guideline No. 37 2009) provide practical recommendations for risk stratification regarding low, intermediate and high risk conditions. At high risk are women with previous VTE or thrombophilia. Corresponding to risk stratification grade C recommendations have been made for VTE prophylaxis during pregnancy and the puerperium. Prophylaxis with low molecular weight heparin (LMWH) should begin as early in pregnancy as practical. In women with lower risk mobilisation, avoidance of dehydration and mechanical methods (e. g., graduated compressive stockings) are sufficient. After delivery women with intermediate risk should be given LMWH for 7 days, women at high risk for 6 weeks or as long as additional risk factors are present. All women who have additional risk factors and who have had an elective Caesarean section should receive prophylactic LMWH for 7 days as should also all women who have had a Caesarean section in labour or an emergency Caesarean section. At the onset of labour, in case of any vaginal bleeding, prior to induction of labour or 12 h before an elective Caesarean section, antenatal LMWH prophylaxis should be discontinued, LMWH prophylaxis can be continued for 4-6 h after vaginal and for 6-12 h after Caesarean delivery when the women do not have an increased risk of haemorrhage. Current guidelines recommend than LMWH are the agents of choice for antenatal thromboprophylaxis; in comparison to unfractionated heparin, LMWH are associated with a substantially lower risk of heparin-induced thrombocytopenia and osteoporosis. Both oral anticoagulants and heparin are safe when breast-feeding.
Assuntos
Anticoagulantes/uso terapêutico , Guias de Prática Clínica como Assunto , Complicações Cardiovasculares na Gravidez/prevenção & controle , Transtornos Puerperais/prevenção & controle , Tromboembolia Venosa/prevenção & controle , Feminino , Alemanha , Humanos , Gravidez , Complicações Cardiovasculares na Gravidez/tratamento farmacológico , Transtornos Puerperais/tratamento farmacológico , Tromboembolia Venosa/tratamento farmacológicoAssuntos
Cesárea/efeitos adversos , Fibrinolíticos/administração & dosagem , Complicações do Trabalho de Parto/etiologia , Complicações do Trabalho de Parto/prevenção & controle , Guias de Prática Clínica como Assunto , Pré-Medicação/normas , Tromboembolia Venosa/prevenção & controle , Medicina Baseada em Evidências , Feminino , Alemanha , Humanos , Gravidez , Resultado do TratamentoRESUMO
Brachial plexus injuries are an interdisciplinary challenge to obstetricians, neonatologists and plexus surgeons. The incidence of brachial plexus injuries is 1-4/1,000 live births, and the incidence of permanent lesions has been estimated to be 1/10,000 live births. Shoulder dystocia is associated with a 75-100-fold increase in plexus injuries. The antenatal (intrauterine) development of brachial plexus injuries is still a matter of controversial debate. The early recognition of antenatal risk factors of shoulder dystocia and its proper management by experienced obstetricians are mandatory; 90% of brachial plexus injuries recover without clinical sequelae for the newborn, however, 10% of the cases may lead to severe pareses requiring surgical intervention. Microsurgical nerve reconstruction should be performed in these cases within the first three months after birth. In this context, the intraoperative findings are of high prognostic relevance. The pathophysiology of birth-associated plexus brachialis injuries has been investigated in recently published experimental studies. An open dialogue between the specialists involved may be a great support for the parents of newborns suffering from plexus brachialis injuries. Medico-legal conflicts lasting for years should be avoided, and appropriate plexus surgical treatment by an experienced surgeon should be offered in good time after a careful diagnosis.
Assuntos
Traumatismos do Nascimento/etiologia , Traumatismos do Nascimento/terapia , Plexo Braquial/lesões , Distocia/etiologia , Distocia/terapia , Extração Obstétrica/efeitos adversos , Período Pós-Parto , Lesões do Ombro , Adulto , Feminino , Alemanha/epidemiologia , Humanos , Incidência , Pessoa de Meia-Idade , Neonatologia/métodos , Neurocirurgia/métodos , Obstetrícia/métodos , Equipe de Assistência ao Paciente , Gravidez , Terceiro Trimestre da Gravidez , Medição de Risco/métodos , Fatores de Risco , Adulto JovemRESUMO
PURPOSE: Our study was performed to obtain additional information regarding the present diagnostic approaches in breast tumor diagnosis by investigating tumor vessels. We present a new method that helps to capture the morphologic features from power Doppler ultrasound images using a computer-aided system facilitating pixel relation analysis techniques in the region of interest (ROI). MATERIALS AND METHODS: 45 solid breast tumors, including 18 benign and 27 malignant histologically proven cases, were studied using quantitative and qualitative parameters with extracted three-dimensional (3D) diagrams. We focused on pixel counting and on physiologic and pathophysiologic vascular analysis over time. P values less than 0.05 using the Wilcoxon, Mann and Whitney's U-test were deemed statistically significant. RESULTS: One of the two quantitative values, the color range, showed a statistical significance for distinguishing between benign and malignant lesions by counting more pixels in malignant cases. We detected differences in the blood flow dynamics with a characteristic flow texture in 89 % of benign lesions and periodic oscillations which were identified with a diagnostic accuracy of 78 % in malignant cases. CONCLUSION: The preliminary results show that the proposed method using power Doppler imaging is feasible and can aid in the classification of breast tumors as benign or malignant.
Assuntos
Doenças Mamárias/diagnóstico por imagem , Neoplasias da Mama/irrigação sanguínea , Neoplasias da Mama/diagnóstico por imagem , Mama/irrigação sanguínea , Ultrassonografia Doppler/métodos , Adulto , Idoso , Idoso de 80 Anos ou mais , Velocidade do Fluxo Sanguíneo , Feminino , Humanos , Pessoa de Meia-Idade , Estudos Prospectivos , Reprodutibilidade dos TestesRESUMO
Paradigm shift is moulded by the rapid advances in scientific knowledge, the results of evidence-based medicine and the guidelines and recommendations resulting therefrom as well as the continuous changes in medicine's social-cultural ambient. Features of a complex medical and social development are the declining number of births, a significant increase in the frequency of caesarean sections and an almost two-fold elevation of the number of induced births. This is especially valid for an overproportional rise in elective induction of labour which, today, represents the most frequently indicated intervention in obstetrics. The elective induction of labour in nulliparous women, however, is associated with an almost two-fold higher incidence of caesarean sections. It is clear for the example of induction of labour that today more than ever obstetric interventions are subject to a broad spectrum of paramedical as well as medical factors and are in fact influenced by them. These include, above all, the pregnant woman's right of self-determination and her individual needs, the logistics and infrastructure of the hospital, the concern about medico-legal disputes, and the increasing economic pressure. In this context the ever increasing competitive situation among the obstetric clinics plays a decisive role. Prerequisite for the induction of labour is an individual risk-use analysis that should be clearly and thoroughly explained to the patient and her partner in a personal conversation. The pregnant woman's frustration about a prolonged course of labour is a complication of the induction that must not be underestimated and leads more often than in the past to a secondary caesarean section. Recent publications warn of an increased maternal morbidity and perinatal mortality in cases of an induction of labour following a previous caesarean section. In contrast to the caesarean saving programme propagated in the 1990s, the historical postulate "once a caesarean always a caesarean" is experiencing an obvious renaissance. Irrespective of the non-medical and medical influencing factors, the obstetrician should not forget his / her own experience and intuition or confidence in his/her own abilities and pass obstetrics on to future generations as an individual art.
Assuntos
Trabalho de Parto Induzido/tendências , Obstetrícia/tendências , Padrões de Prática Médica/tendências , Feminino , Humanos , GravidezAssuntos
Proteínas Angiogênicas/sangue , Pré-Eclâmpsia/diagnóstico , Pré-Eclâmpsia/prevenção & controle , Modelos de Riscos Proporcionais , Biomarcadores/sangue , Determinação da Pressão Arterial , Medicina Baseada em Evidências , Feminino , Alemanha/epidemiologia , Humanos , Pré-Eclâmpsia/sangue , Pré-Eclâmpsia/epidemiologia , Gravidez , Prevalência , Prognóstico , Análise de Onda de Pulso/estatística & dados numéricos , Reprodutibilidade dos Testes , Fatores de Risco , Sensibilidade e Especificidade , UltrassonografiaRESUMO
OBJECTIVE: The enzyme 11ß-dehydroxysteroid dehydrogenase 2 (11ß-HSD2) converts active cortisol (F) to inactive cortisone (E). A reduced 11ß-HSD2 activity in the placenta has been demonstrated for prematurity, low birth weight, and preeclampsia. We hypothesized that disturbed placental function rather than a maternal response contributes to decreased 11ßHSD2 activity as reflected by a diminished conversion of F to E. Hence, the aim of the present study was to estimate the systemic activity of 11ß-HSD2 throughout gestation and in pregnancies complicated by preeclampsia (PE) and intrauterine growth restriction (IUGR) by calculating maternal serum F/E ratios. METHODS: A total of 188 maternal serum samples were analyzed for nine glucocorticoid metabolites by gas chromatography-mass spectrometry (GC-MS) and F/E ratios were calculated. Study Group A: In a longitudinal set 33 healthy pregnant women were analyzed at three different time points throughout gestation and one postpartum. Study Group B: Cross-sectionally additional 56 patients were enrolled. We compared patients with PE (Nâ¯=â¯14) and IUGR (Nâ¯=â¯14) with gestational age matched healthy controls (CTRLâ¯=â¯28). RESULTS: Group A: The apparent 11ß-HSD2 activity dropped in the second trimester being restored to first trimester levels (P valueâ¯=â¯0.016). Group B: The 11ß-HSD2 activity was high in PE (P valueâ¯<â¯0.05) but not in the IUGR group as compared to CTRL. CONCLUSION: The increased apparent serum 11ß-HSD2 activity observed with advancing gestation in normal pregnancy may reflect an elevated general increase in enzyme activity due to a higher placental mass. The high systemic 11ß-HSD2 activity in PE but not in IUGR however suggests an increased F deactivation in maternal tissue in PE rather than in the placenta since placental insufficiency in the absence of PE does not significantly alter F/E ratio.
Assuntos
11-beta-Hidroxiesteroide Desidrogenase Tipo 2/sangue , Retardo do Crescimento Fetal/sangue , Pré-Eclâmpsia/sangue , Adulto , Biomarcadores/sangue , Estudos de Casos e Controles , Cortisona/sangue , Estudos Transversais , Feminino , Retardo do Crescimento Fetal/diagnóstico , Retardo do Crescimento Fetal/enzimologia , Idade Gestacional , Humanos , Hidrocortisona/sangue , Estudos Longitudinais , Pré-Eclâmpsia/diagnóstico , Pré-Eclâmpsia/enzimologia , Gravidez , Regulação para CimaRESUMO
Thromboembolic complications remain an important cause of maternal mortality. The present recommendations favour for prophylaxis unfractionated (UFH) and low molecular weight heparin (LMWH). We investigated 150 pregnant women before and after cesarean section in three randomized groups. Fifty women received no prophylaxis (group I), 50 women UFH two times 5000 IU/day (group III) and 50 women Dalteparin 5000 U/day (group II). We determined the blood count, the rheological parameters and cholesterol, triglycerides, D-dimer, fibrinogen and the anti-Xa-level. We found a classical hemodilution, with increase of erythrocyte aggregation and plasma viscosity postoperatively. The fibrinogen turnover and D-dimer concentration were elevated. The patients with Dalteparin prophylaxis showed lower thrombin activation, minor changes in the cholesterol and triglycerides level and an improvement of red cell deformability in low shear regions. Our results demonstrated an influence of Dalteparin on the rheological parameters post surgery. The DVT incidence was 1.33% generally and occurred only in the Control group and in women with unfractionated heparin. We observed no side effects such as major bleeding, osteopenia or allergy.